Nuclear DNA content and p53 overexpression in stage I squamous cell carcinoma of the tongue compared with advanced tongue carcinomas

Journal of Clinical Pathology - Molecular Pathology

Volumn 51, Issue 5, 1998, Pages 268-272

  Hogmo A ^a   Kuylenstierna, R ^a   Lindholm, J ^a   Nathansson, A ^b   Auer, G ^a   Munck Wikland, E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

DNA; Protein p53; Squamous cell carcinoma

Indexed keywords

CELL NUCLEUS DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; DNA CONTENT; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

EID: 0031724846     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.51.5.268     Document Type: Article

References (26)

1. Biörklund A, Anderson H, Möller T, et al. Carcinoma of the tongue in young adults. Clin Otolaryngol 1995;20:186.
2. Nathansson A, Agren K, Biörklund A, et al. Evaluation of some prognostic factors in small squamous cell carcinoma of the mobile tongue: a multicenter study in Sweden. Head Neck 1989;11:387-92.
3. Odell EW, Piyush J, Sherriff M, et al. The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas. The importance of the pattern of invasion. Cancer 1994;74:789-94.
4. Gomez R, El-Naggar AK, Byers RM, et al. Squamous carcinoma of oral tongue: prognostic significance of flow-cytometric DNA content. Mod Pathol 1992;5:141-5.
5. Cooke LD, Cooke TG, Forster G, et al. Flow cytometric analysis of DNA content in squamous carcinoma of the tongue: the relationship to host and tumour factors and survival. Clin Otolaryngol 1994;19:131-4.
6. Saito T, Sato J, Satoh A, et al. Flow cytometric analysis of nuclear DNA content in tongue squamous cell carcinoma: relation to cervical lymph node metastasis. Int J Oral Maxillofac Surg 1994;23:28-31.
7. Högmo A, Munek-Wikland E, Kuylenstierna R, et al. Nuclear DNA content and p53 immunostaining in oral squamous cell carcinoma an analysis of a consecutive 10-year material. Int J Oncol 1994;5:915-20.
8. Zätterström U, Wennerberg J, Ewers SB, et al. Prognostic factors in head and neck cancer: histologic grading, DNA ploidy and nodal status. Head Neck 1991;13:477-87.
9. Munck-Wikland E, Kuylenstierna R, Lind M, et al. The prognostic value of cytometric DNA analysis in early stage tongue cancer. Oral Oncol Eur J Cancer 1992;28B:135-8.
10. Field JR, Spandidos DA, Malliri A, et al. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 1991;64:573-7.
11. Watling D, Gown A, Coltrera M. Overexpression of p5 in head and neck cancer. Head Neck 1992;14:437-44.
12. Langdon J, Partridge M. Expression of the tumour suppressor gene p53 in oral cancer. Br J Oral Maxillofac Surg1992; 30:214-20.
13. Shin D, Lee JS, Lippman S, et al. p53 expression: predicting recurrence and secondary primary tumours in head and neck squamous cell carcinoma. J Natl Cancer 1996;88: 519-29.
14. Bischoff JR, Kirn DH, Willliams A, et al. An adenovirus mutant that replicates selectively in p53-deficient human tumour cells. Science 1996;274:373-6.
15. Auer G, Askensten U, Ahrens O. Cytophotometry. Hum Pathol 1989;20:518-27.
16. Munck-Wikland E, Rubio CA, Auer G, et al. Control cells for image cytometric DNA analysis of esophageal tissue and the influence of preopretaive treatment. Anal Quant Cyytol Histol 1990;12:267-74.
17. Broders A. The microscopic grading of cancer. Surg Clin North Am 1941;21:947-62.
18. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium. Cancer 1953;6:963-8.
19. Munck-Wikland E, Blegen H, Lewensohn-Fuuchs I, et al. p53 overexpression in normal and dysplastic tissues adjacent to p53 negative squamous cell carcinomas of the head and neck. Int J Oncol 1997;11:97-104.
20. Xu L, Chen Y-T, Huvos A, et al. Overexpression of p53 protein in squamous cell carcinomas of the head and neck without apparent gene mutations. Diagn Mol Pathol 1994;3:83-92.
21. Nylander K, Nilsson P, Mehle C, et al. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck. Br J Cancer 1995;71:826-30.
22. Gluckman JL, Stambrook PJ, Pavelic ZP. Prognostic significance of p53 protein accumulation in early stage T1 oral cavity cancer. Oral Oncol Eur J Cancer 1994;30B:281.
23. Leedy DA, Trune DR, Kronz JD, et al. Tumour angiogenesis, the p53 antigen, and cervical metastasis in squamous cell carcinoma of the tongue. Otolaryngol Head Neck Surg 1994;111:417-22.
24. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972;29:1446-9.
25. Nowell PC. The clonal evolution of tumour cell populations. Science 1976;194:23-8.
26. El-Naggar AK, Lopez-Varela V, Luna MA, et al. Intratumoural DNA content heterogeneity in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1992;118: 169-73.